Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Melanoma

Free Subscription 02.12.2024 2 Ann Surg Oncol 2 Br J Dermatol 3 Eur J Dermatol 8 J Am Acad Dermatol 1 J Invest Dermatol 1 Melanoma Res 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. MEVES A
   ASO Author Reflections: From SLNB to Neoadjuvant Therapy: How CP-GEP Might Help Shape the Future of Melanoma Treatment.
   Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16615.
   PubMed        
   
   
2. PAZHAVA A, Yu WY, Jing FZ, Hill S, et al
   Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP).
   Ann Surg Oncol. 2024 Nov 23. doi: 10.1245/s10434-024-16551.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

3. KARINE B, Mortier L, Dereure O, Dalac S, et al
   The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab versus nivolumab in a real-world setting.
   Br J Dermatol. 2024 Nov 28:ljae470. doi: 10.1093.
   PubMed         Abstract available
   
   
4. WOLBER AK, Jayasinghe D, Betz-Stablein B, Janda M, et al
   Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma.
   Br J Dermatol. 2024 Nov 26:ljae467. doi: 10.1093.
   PubMed        
   
   

   
   Eur J Dermatol

5. SUGIYAMA T, Fukuchi K, Kitauchi Y, Shimauchi T, et al
   A case of BRAF inhibitor-induced pancreatitis in a patient with malignant melanoma.
   Eur J Dermatol. 2024;34:563-564.
   PubMed        
   
   
6. KAMBAYASHI Y, Fujimura T, Takahashi T, Hashimoto A, et al
   Disseminated bone marrow carcinomatosis of malignant melanoma: a case report and review of the literature.
   Eur J Dermatol. 2024;34:561-562.
   PubMed        
   
   
7. DRADI GG, Villegas RG, Murzubal MUF, Moraleda FP, et al
   Parallel pigmented network in lentigo maligna: a case series and correlation with in vivo reflectance confocal microscopy.
   Eur J Dermatol. 2024;34:490-496.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

8. TOMSITZ D, Kerl K, French LE, Heinzerling L, et al
   Clinical and pathological characterization of tebentafusp-associated skin toxicity: A cohort study with 33 patients.
   J Am Acad Dermatol. 2024;91:1136-1142.
   PubMed         Abstract available
   
   
9. ZHANG Y, Wu J, Cai X, Jiang K, et al
   Nevus-associated acral melanoma has lower risk of recurrence and mortality than de novo acral melanoma: A multicenter, retrospective analysis of 482 patients.
   J Am Acad Dermatol. 2024 Nov 20:S0190-9622(24)03237.
   PubMed         Abstract available
   
   
10. TAYLOR MA, Sharma D, Thomas S, Wei EX, et al
    Reduced Disease-Specific Mortality in Melanoma in situ Patients Treated with Mohs Surgery over Wide Local Excision: A Study of the Surveillance, Epidemiology, and End Results Database.
    J Am Acad Dermatol. 2024 Nov 20:S0190-9622(24)03225.
    PubMed        
    
    
11. ROSENTHAL A, Kim JY, Juhasz ML, Conde G, et al
    Tumor Upstaging in Invasive Melanoma is Associated with Changes in Clinical Management and Worse Prognosis.
    J Am Acad Dermatol. 2024 Nov 21:S0190-9622(24)03233.
    PubMed         Abstract available
    
    
12. HUANG Y, Fleming P, Fung K, Chan AW, et al
    Response to Tang et al., "Insufficient evidence for association between dermatology follow-up and melanoma survival".
    J Am Acad Dermatol. 2024 Nov 21:S0190-9622(24)03240.
    PubMed        
    
    
13. TANG J, Cheng HR
    Insufficient evidence for association between dermatology follow-up and melanoma survival.
    J Am Acad Dermatol. 2024 Nov 21:S0190-9622(24)03241.
    PubMed        
    
    
14. SHAFIQUE N, Ertmann E, Tortorello G, Karakousis GC, et al
    Desmoplastic melanoma in the era of immune checkpoint blockade.
    J Am Acad Dermatol. 2024 Nov 25:S0190-9622(24)03251.
    PubMed        
    
    
15. KIM DY, Lin JY, Hartman RI
    Refusal of Surgery Among Cutaneous Melanoma Patients: Clinical Predictors and Impacts on Melanoma-Specific Survival.
    J Am Acad Dermatol. 2024 Nov 26:S0190-9622(24)03272.
    PubMed        
    
    

    
    J Invest Dermatol

16. LIU X, Janknecht R, Asadbeigi SN, Perry L, et al
    The influence of melanoma extracellular vesicles on benign melanocytes: a role for PRAME in modulation of the tumor microenvironment.
    J Invest Dermatol. 2024 Nov 26:S0022-202X(24)02959.
    PubMed         Abstract available
    
    

    
    Melanoma Res

17. NIU L, Liu S, Shen J, Chang J, et al
    ATF3 regulates CDC42 transcription and influences cytoskeleton remodeling, thus inhibiting the proliferation, migration and invasion of malignant skin melanoma cells.
    Melanoma Res. 2024 Nov 26. doi: 10.1097/CMR.0000000000001011.
    PubMed         Abstract available
    
    

    
    Oncogene

18. WHABY M, Ketavarapu G, Koide A, Mazzei M, et al
    Inhibition and degradation of NRAS with a pan-NRAS monobody.
    Oncogene. 2024;43:3489-3497.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.